Strategies For Flexible Manufacturing

Source: Catalent

By Alton Johnson, Ph.D., Principal, NGT Biopharma Consultants, and Katie Noah, R&D Project Manager, Catalent


Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs. New products are increasingly complex and must be developed in shorter timelines to meet patient needs. With the recent rise in accelerated designations (i.e., orphan drugs, fast track, etc.), advanced manufacturing technologies and smaller batch sizes are a growing trend. Read this executive summary for an in-depth look at flexible manufacturing including, the latest market drivers, approaches, and technology.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online